SK
Savitri Kumari
About Savitri Kumari
Data last updated:
Savitri Kumari is a Director at Novarex Pharma Private Limited (since 2023) and Director at Pinnacle Pharma Private Limited (since 2025). The companies operate in Paper. The largest current company by reported revenue is Novarex Pharma Private Limited at ₹4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novarex Pharma Private Limited U21009DL2023PTC415813 | Director | 12 Jun 2023 | 2023 | ₹4 Lakh (FY 2025) | Active |
| Pinnacle Pharma Private Limited U46497TS2025PTC205814 | Director | 31 Oct 2025 | 2025 | Active |
Board colleagues of Savitri Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shweta Priya | 10215649 | Novarex Pharma Private Limited , Pinnacle Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Savitri Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Savitri Kumari
Savitri Kumari currently holds 2 directorships: Novarex Pharma Private Limited (Director, since 12 Jun 2023, revenue ₹4 Lakh (FY 2025)); Pinnacle Pharma Private Limited (Director, since 31 Oct 2025).
Savitri Kumari was first appointed on 12 Jun 2023 as Director at Novarex Pharma Private Limited. The most recent appointment on record is 31 Oct 2025 at Pinnacle Pharma Private Limited.
The current boards of Savitri Kumari's companies include Shweta Priya (Novarex Pharma Private Limited).